These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 10217649)
1. Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. Schwinger RH; Wang J; Frank K; Müller-Ehmsen J; Brixius K; McDonough AA; Erdmann E Circulation; 1999 Apr; 99(16):2105-12. PubMed ID: 10217649 [TBL] [Abstract][Full Text] [Related]
2. Region specific regulation of sodium pump isoform and Na,Ca-exchanger expression in the failing human heart--right atrium vs left ventricle. Müller-Ehmsen J; Wang J; Schwinger RH; McDonough AA Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):373-81. PubMed ID: 11357898 [TBL] [Abstract][Full Text] [Related]
3. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium. Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852 [TBL] [Abstract][Full Text] [Related]
4. The cardiac sodium pump: structure and function. McDonough AA; Velotta JB; Schwinger RH; Philipson KD; Farley RA Basic Res Cardiol; 2002; 97 Suppl 1():I19-24. PubMed ID: 12479229 [TBL] [Abstract][Full Text] [Related]
5. Regional expression of sodium pump subunits isoforms and Na+-Ca++ exchanger in the human heart. Wang J; Schwinger RH; Frank K; Müller-Ehmsen J; Martin-Vasallo P; Pressley TA; Xiang A; Erdmann E; McDonough AA J Clin Invest; 1996 Oct; 98(7):1650-8. PubMed ID: 8833915 [TBL] [Abstract][Full Text] [Related]
6. Enhanced sensitivity of the failing human myocardium to cardiac glycosides and Na(+)-channel activators. Schwinger RH; Müller-Ehmsen J; Frank K; Koch A; Erdmann E Am Heart J; 1996 May; 131(5):988-93. PubMed ID: 8615321 [TBL] [Abstract][Full Text] [Related]
7. Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium. Flesch M; Schwinger RH; Schiffer F; Frank K; Südkamp M; Kuhn-Regnier F; Arnold G; Böhm M Circulation; 1996 Sep; 94(5):992-1002. PubMed ID: 8790037 [TBL] [Abstract][Full Text] [Related]
8. Increased functional importance of the Na,Ca-exchanger in contracting failing human myocardium but unchanged activity in isolated vesicles. Diedrichs H; Frank K; Schneider CA; Burst V; Hagemeister J; Zobel C; Müller-Ehmsen J Int Heart J; 2007 Nov; 48(6):755-66. PubMed ID: 18160767 [TBL] [Abstract][Full Text] [Related]
9. Na(+)-channel activators increase cardiac glycoside sensitivity in failing human myocardium. Schwinger RH; Böhm M; La Rosée K; Schmidt U; Schulz C; Erdmann E J Cardiovasc Pharmacol; 1992 Apr; 19(4):554-61. PubMed ID: 1380598 [TBL] [Abstract][Full Text] [Related]
10. Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium. Schwinger RH; Böhm M; Mittmann C; La Rosée K; Erdmann E J Mol Cell Cardiol; 1991 Apr; 23(4):461-71. PubMed ID: 1658340 [TBL] [Abstract][Full Text] [Related]
11. Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium. Schwinger RH; Müller-Ehmsen J; Böhm M; Erdmann E J Pharmacol Exp Ther; 1996 Mar; 276(3):1180-8. PubMed ID: 8786551 [TBL] [Abstract][Full Text] [Related]
12. Role of Na Dhalla NS; Elimban V; Adameova AD Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409137 [TBL] [Abstract][Full Text] [Related]
14. Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure. Studer R; Reinecke H; Bilger J; Eschenhagen T; Böhm M; Hasenfuss G; Just H; Holtz J; Drexler H Circ Res; 1994 Sep; 75(3):443-53. PubMed ID: 8062418 [TBL] [Abstract][Full Text] [Related]
15. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Schwinger RH; Böhm M; Schmidt U; Karczewski P; Bavendiek U; Flesch M; Krause EG; Erdmann E Circulation; 1995 Dec; 92(11):3220-8. PubMed ID: 7586307 [TBL] [Abstract][Full Text] [Related]
16. Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium. Müller-Ehmsen J; Brixius K; Schwinger RH J Cardiovasc Pharmacol; 1998 May; 31(5):684-9. PubMed ID: 9593067 [TBL] [Abstract][Full Text] [Related]
17. Low-dose ouabain administration increases Na⁺,K⁺-ATPase activity and reduces cardiac force development in rats. Meira EF; Siman FD; Faria Tde O; Júnior RF; de Batista PR; Stefanon I; Vassallo DV; Padilha AS Pharmacol Rep; 2015 Apr; 67(2):253-9. PubMed ID: 25712647 [TBL] [Abstract][Full Text] [Related]
18. Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts. Schwinger RH; Hoischen S; Reuter H; Hullin R J Mol Cell Cardiol; 1999 Jan; 31(1):283-96. PubMed ID: 10072735 [TBL] [Abstract][Full Text] [Related]
19. Na+/K+ ATPase and its functional coupling with Na+/Ca2+ exchanger in mouse embryonic stem cells during differentiation into cardiomyocytes. Otsu K; Kuruma A; Yanagida E; Shoji S; Inoue T; Hirayama Y; Uematsu H; Hara Y; Kawano S Cell Calcium; 2005 Feb; 37(2):137-51. PubMed ID: 15589994 [TBL] [Abstract][Full Text] [Related]
20. Isoform-specific regulation of myocardial Na,K-ATPase alpha-subunit in congestive heart failure. Role of norepinephrine. Kim CH; Fan TH; Kelly PF; Himura Y; Delehanty JM; Hang CL; Liang CS Circulation; 1994 Jan; 89(1):313-20. PubMed ID: 8281663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]